Literature DB >> 23477110

Identification of risk factors for fatigue and pain when performing surgical interventions.

Alessandra Rodigari1, Maurizio Bejor, Ettore Carlisi, Claudio Lisi, Carmine Tinelli, Elena Dalla Toffola.   

Abstract

OBJECTIVE: Evaluation of fatigue and pain following surgical activities.
METHODS: Cross-sectional study. We distributed a self-evaluation questionnaire to 180 surgeons to investigate working postures and fatigue and/or pain following working activities.
RESULTS: 100 surgeons replied (74 male), mean age 40.1 (SD 10.85; 26-65). Multivariate analysis suggests that the highest risk factor for developing muscle fatigue whilst performing surgical operations is standing compared to sitting (OR: 4.92; 95% CI: 1.32-18.33),followed by the ability to alternate between the two postures (OR: 3.46: 95% CI: 1.26-9.52). Surgeons who complain of intense fatigue when standing have 16 times the risk of developing musculoskeletal pain than surgeons who complain of light fatigue when standing (OR: 15.77; 95% CI: 1.51-164.37). The ability to adjust the height of the operating table before each operation reduces the risk of developing musculoskeletal pain by 83% (OR: 017; 95% CI: 0.03-0.87); 90.9% of surgeons who rest their forearms for less than half the duration of an operation reported pain.
CONCLUSIONS: Fatigue and pain associated with performing surgical interventions could be managed more effectively by: controlling the working posture, being able to rest forearms, being able to regulate the height of the operating table, and possibly by applying the ergonomic guidelines.

Entities:  

Mesh:

Year:  2012        PMID: 23477110

Source DB:  PubMed          Journal:  G Ital Med Lav Ergon        ISSN: 1592-7830


  1 in total

1.  Prevalence of Work-Related Musculoskeletal Disorders Among Surgeons and Interventionalists: A Systematic Review and Meta-analysis.

Authors:  Sherise Epstein; Emily H Sparer; Bao N Tran; Qing Z Ruan; Jack T Dennerlein; Dhruv Singhal; Bernard T Lee
Journal:  JAMA Surg       Date:  2018-02-21       Impact factor: 14.766

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.